There is also proof that managing calcitriol levels may lessen some of the unfavorable downwind immunological complications associated with the infection of COVID-19, such as an IL-6 surge, postponed IF-γ reactions, and an adverse prognostic indicator in individuals with acute illness pneumonia, even those with COVID-19 infectious disease [9,109]. The gene discussed is IL6; the disease is COVID-19.